Tight regulation of p53 activity by Mdm2 is required for ureteric bud growth and branching

Developmental Biology

Volumn 353, Issue 2, 2011, Pages 354-366

  Hilliard, Sylvia ^a   Aboudehen, Karam ^a   Yao, Xiao ^a   El Dahr, Samir S ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Branching morphogenesis; Developing kidney; Mdm2; Nephrogenesis; P53; Ureteric bud

Indexed keywords

MESSENGER RNA; PROTEIN MDM2; PROTEIN P53;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRANCHING MORPHOGENESIS; C RET GENE; CELL CULTURE; CELL CYCLE ARREST; CELL INTERACTION; CELL LINEAGE; CONTROLLED STUDY; EMBRYO; EPITHELIUM CELL; EX VIVO STUDY; GENE; GENE DELETION; GENE EXPRESSION; GENETIC REGULATION; KIDNEY DEVELOPMENT; KIDNEY DYSPLASIA; LHX 1 GENE; MDM2 GENE; MESENCHYME CELL; MOUSE; NEPHRON; NONHUMAN; NUCLEOTIDE SEQUENCE; P53 GENE; PAX 2 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RENAL HYPODYSPLASIA; URETER; URETER BUD; WNT11 GENE; WNT9B GENE;

MURINAE; MUS;

EID: 79955028635     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2011.03.017     Document Type: Article

References (57)

1. al-Awqati Q., Goldberg M.R. Architectural patterns in branching morphogenesis in the kidney. Kidney Int. 1998, 54:1832-1842.
2. Barak Y., Juven T., Haffner R., Oren M. Mdm2 expression is induced by wild type p53 activity. EMBO 1993, J12:461-468.
3. Basson M.A., Watson-Johnson J., Shakya R., Akbulut S., Hyink D., Costantini F.D., Wilson P.D., Mason I.J., Licht J.D. Branching morphogenesis of the ureteric epithelium during kidney development is coordinated by the opposing functions of GDNF and Sprouty1. Dev. Biol. 2006, 299:466-477.
4. Bates C.M. Kidney development: regulatory molecules crucial to both mice and men. Mol. Genet. Metab. 2000, 71:391-396.
5. Boesten L.S., Zadelaar S.M., De Clercq S., Francoz S., van Nieuwkoop A., Biessen E.A., Hofmann F., Feil S., Feil R., Jochemsen A.G., Zurcher C., Havekes L.M., van Vlijmen B.J., Marine J.C. Mdm2, but not Mdm4, protects terminally differentiated smooth muscle cells from p53-mediated caspase-3-independent cell death. Cell Death Differ. 2006, 13:2089-2098.
6. Bond G.L., Hu W., Bond E.E., Robins H., Lutzker S.G., Arva N.C., Bargonetti J., Bartel F., Taubert H., Wuerl P., Onel K., Yip L., Hwang S.J., Strong L.C., Lozano G., Levine A.J. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 2004, 119:591-602.
7. Brenner B.M., Garcia D.L., Anderson S. Glomeruli and blood pressure. Less of one, more the other?. Am. J. Hypertens. 1988, 1:335-347.
8. Bridgewater D., Cox B., Cain J., Lau A., Athaide V., Gill P.S., Kuure S., Sainio K., Rosenblum N.D. Canonical WNT/beta-catenin signaling is required for ureteric branching. Dev. Biol. 2008, 317:83-94.
9. Brophy P.D., Ostrom L., Lang K.M., Dressler G.R. Regulation of ureteric bud outgrowth by Pax2-dependent activation of the glial derived neurotrophic factor gene. Development 2001, 128:4747-4756.
10. Bush K.T., Vaughn D.A., Li X., Rosenfeld M.G., Rose D.W., Mendoza S.A., Nigam S.K. Development and differentiation of the ureteric bud into the ureter in the absence of a kidney collecting system. Dev. Biol. 2006, 298:571-584.
11. Cain J.E., Di Giovanni V., Smeeton J., Rosenblum N.D. Genetics of renal hypoplasia: insights into the mechanisms controlling nephron endowment. Pediatr. Res. 2010, 68:91-98.
12. Carroll T.J., Park J.S., Hayashi S., Majumdar A., McMahon A.P. Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system. Dev. Cell 2005, 9:283-292.
13. Chavez-Reyes A., Parant J.M., Amelse L.L., de Oca Luna R.M., Korsmeyer S.J., Lozano G. Switching mechanisms of cell death in mdm2- and mdm4-null mice by deletion of p53 downstream targets. Cancer Res. 2003, 63:8664-8669.
14. Costantini F. Renal branching morphogenesis: concepts, questions, and recent advances. Differentiation 2006, 74:402-421.
15. Costantini F., Kopan R. Patterning a complex organ: branching morphogenesis and nephron segmentation in kidney development. Dev. Cell 2010, 18:698-712.
16. de Rozieres S., Maya R., Oren M., Lozano G. The loss of mdm2 induces p53-mediated apoptosis. Oncogene 2000, 19:1691-1697.
17. Dressler G.R. Advances in early kidney specification, development and patterning. Development 2009, 136:3863-3874.
18. Fakharzadeh S.S., Trusko S.P., George D.L. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO 1991, J10:1565-1569.
19. Francoz S., Froment P., Bogaerts S., De Clercq S., Maetens M., Doumont G., Bellefroid E., Marine J.C. Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo. Proc. Natl. Acad. Sci. USA 2006, A103:3232-3237.
20. Godley L.A., Kopp J.B., Eckhaus M., Paglino J.J., Owens J., Varmus H.E. Wild-type p53 transgenic mice exhibit altered differentiation of the ureteric bud and possess small kidneys. Genes Dev. 1996, 10:836-850.
21. Grier J.D., Xiong S., Elizondo-Fraire A.C., Parant J.M., Lozano G. Tissue-specific differences of p53 inhibition by Mdm2 and Mdm4. Mol. Cell. Biol. 2006, 26:192-198.
22. Harris S.L., Levine A.J. The p53 pathway: positive and negative feedback loops. Oncogene 2005, 24:2899-2908.
23. Haupt Y., Maya R., Kazaz A., Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997, 387:296-299.
24. Ishibe S., Karihaloo A., Ma H., Zhang J., Marlier A., Mitobe M., Togawa A., Schmitt R., Czyczk J., Kashgarian M., Geller D.S., Thorgeirsson S.S., Cantley L.G. Met and the epidermal growth factor receptor act cooperatively to regulate final nephron number and maintain collecting duct morphology. Development 2009, 136:337-345.
25. Jacks T., Remington L., Williams B.O., Schmitt E.M., Halachmi S., Bronson R.T., Weinberg R.A. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 1994, 4:1-7.
26. Jones S.N., Roe A.E., Donehower L.A., Bradley A. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 1995, 378:206-208.
27. Keller G., Zimmer G., Mall G., Ritz E., Amann K. Nephron number in patients with primary hypertension. N. Engl. J. Med. 2003, 348:101-108.
28. Kim D., Dressler G.R. PTEN modulates GDNF/RET mediated chemotaxis and branching morphogenesis in the developing kidney. Dev. Biol. 2007, 307:290-299.
29. Kobayashi A., Kwan K.M., Carroll T.J., McMahon A.P., Mendelsohn C.L., Behringer R.R. Distinct and sequential tissue-specific activities of the LIM-class homeobox gene Lim1 for tubular morphogenesis during kidney development. Development 2005, 132:2809-2823.
30. Kubbutat M.H., Jones S.N., Vousden K.H. Regulation of p53 stability by Mdm2. Nature 1997, 387:299-303.
31. Lechner M.S., Dressler G.R. The molecular basis of embryonic kidney development. Mech. Dev. 1997, 62:105-120.
32. Lengner C.J., Steinman H.A., Gagnon J., Smith T.W., Henderson J.E., Kream B.E., Stein G.S., Lian J.B., Jones S.N. Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling. J. Cell Biol. 2006, 172:909-921.
33. Lozano G., Montes de Oca Luna R. MDM2 function. Biochim. Biophys. Acta 1998, 1377:M55-M59.
34. Marine J.C., Dyer M.A., Jochemsen A.G. MDMX: from bench to bedside. J. Cell Sci. 2007, 120:371-378.
35. Marose T.D., Merkel C.E., McMahon A.P., Carroll T.J. Beta-catenin is necessary to keep cells of ureteric bud/Wolffian duct epithelium in a precursor state. Dev. Biol. 2008, 314:112-126.
36. Mayo L.D., Donner D.B. The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network. Trends Biochem. Sci. 2002, 27:462-467.
37. Mendrysa S.M., McElwee M.K., Michalowski J., O'Leary K.A., Young K.M., Perry M.E. Mdm2 Is critical for inhibition of p53 during lymphopoiesis and the response to ionizing irradiation. Mol. Cell. Biol. 2003, 23:462-472.
38. Momand J., Zambetti G.P., Olson D.C., George D., Levine A.J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992, 69:1237-1245.
39. Montes de Oca Luna R., Wagner D.S., Lozano G. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 1995, 378:203-206.
40. Moumen A., Patane S., Porras A., Dono R., Maina F. Met acts on Mdm2 via mTOR to signal cell survival during development. Development 2007, 134:1443-1451.
41. Nigam S.K., Shah M.M. How does the ureteric bud branch?. J. Am. Soc. Nephrol. 2009, 20:1465-1469.
42. Oliner J.D., Pietenpol J.A., Thiagalingam S., Gyuris J., Kinzler K.W., Vogelstein B. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 1993, 362:857-860.
43. Oren M., Damalas A., Gottlieb T., Michael D., Taplick J., Leal J.F., Maya R., Moas M., Seger R., Taya Y., Ben-Ze'ev A. Regulation of p53: intricate loops and delicate balances. Biochem. Pharmacol. 2002, 64:865-871.
44. Perry M.E., Piette J., Zawadzki J.A., Harvey D., Levine A.J. The mdm-2 gene is induced in response to UV light in a p53-dependent manner. Proc. Natl. Acad. Sci. USA 1993, A90:11623-11627.
45. Poladia D.P., Kish K., Kutay B., Bauer J., Baum M., Bates C.M. Link between reduced nephron number and hypertension: studies in a mutant mouse model. Pediatr. Res. 2006, 59:489-493.
46. Poyurovsky M.V., Prives C. Unleashing the power of p53: lessons from mice and men. Genes Dev. 2006, 20:125-131.
47. Reidy K.J., Rosenblum N.D. Cell and molecular biology of kidney development. Semin. Nephrol. 2009, 29:321-337.
48. Rothenpieler U.W., Dressler G.R. Pax-2 is required for mesenchyme-to-epithelium conversion during kidney development. Development 1993, 119:711-720.
49. Saifudeen Z., Dipp S., Stefkova J., Yao X., Lookabaugh S., El-Dahr S.S. p53 regulates metanephric development. J. Am. Soc. Nephrol. 2009, 20:2328-2337.
50. Stambolic V., MacPherson D., Sas D., Lin Y., Snow B., Jang Y., Benchimol S., Mak T.W. Regulation of PTEN transcription by p53. Mol. Cell 2001, 8:317-325.
51. Terzian T., Wang Y., Van Pelt C.S., Box N.F., Travis E.L., Lozano G. Haploinsufficiency of Mdm2 and Mdm4 in tumorigenesis and development. Mol. Cell. Biol. 2007, 27:5479-5485.
52. Torres M., Gomez-Pardo E., Dressler G.R., Gruss P. Pax-2 controls multiple steps of urogenital development. Development 1995, 121:4057-4065.
53. Wade M., Wang Y.V., Wahl G.M. The p53 orchestra: Mdm2 and Mdmx set the tone. Trends Cell Biol. 2010, 20:299-309.
54. Woods L.L. Neonatal uninephrectomy causes hypertension in adult rats. Am. J. Physiol. 1999, 276:R974-R978.
55. Xiong S., Van Pelt C.S., Elizondo-Fraire A.C., Liu G., Lozano G. Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development. Proc. Natl. Acad. Sci. USA 2006, A103:3226-3231.
56. Xiong S., Van Pelt C.S., Elizondo-Fraire A.C., Fernandez-Garcia B., Lozano G. Loss of Mdm4 results in p53-dependent dilated cardiomyopathy. Circulation 2007, 115:2925-2930.
57. Zhao H., Kegg H., Grady S., Truong H.T., Robinson M.L., Baum M., Bates C.M. Role of fibroblast growth factor receptors 1 and 2 in the ureteric bud. Dev. Biol. 2004, 276:403-415.